Lichen planus

Oct 09, 2019

AFYX Therapeutics Presents Results from Rivelin Clinical Proof of Concept Study in Patients with Vulvar Lichen Sclerosus at the 2019 European Academy of Dermatology and Venereology Congress

Jun 24, 2019

AFYX Therapeutics Closes $13 Million Convertible Loan Financing

May 23, 2019

AFYX Therapeutics Presents Framework for Patient-Reported Oral Lichen Planus Symptom Severity Measure at the 2019 American Academy of Oral Medicine Annual Conference

Dec 04, 2018

AFYX Therapeutics Announces Completion of Enrollment in Phase 1 Clinical Trial of the Rivelin Patch in Patients with Vulvar Lichen Sclerosus

Sep 27, 2018

AFYX Therapeutics Presents Clinical and Preclinical Research on Rivelin Treatment for Mucosal Diseases at 14th Biennial Congress of European Association of Oral Medicine

Jul 23, 2018

Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus

Apr 25, 2018

Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego